Search Results 141-150 of 16855 for CLL

  1. A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia - Mayo Clinic

    ... Chronic Lymphocytic Leukemia. Print details. Share; Facebook · Twitter ... CLL. Globally, 265 subjects may be enrolled into 4 treatment arms, including ...

  2. Spinal Cord Lymphoma Clinical Trials - Mayo Clinic Research

    ... Chronic Lymphocytic Leukemia (CLL) with controls from a normal household and age-matched population. A Study of Nivolumab in Relapsed/Refractory Primary ...

  3. Paul J. Hampel, M.D. - Doctors and Medical Staff - Mayo Clinic

    Paul Hampel, M.D., is a board-certified hematologist and oncologist specializing in lymphoproliferative diseases, including chronic lymphocytic leukemia, ...

  4. A Study of GDC-0199 (ABT-199) Plus MabThera/Rituxan (Rituximab) Compared with Bendamustine Plus MabThera/Rituxan (Rituximab) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    Diagnosis of chronic lymphocytic leukemia (CLL) per diagnostic criteria and relapsed or refractory CLL per the iwCLL guidelines. Previously treated with 1-3 ...

  5. Neil E. Kay, M.D. - Doctors and Medical Staff - Mayo Clinic

    CLL Society's Integrative Medicine Award-Selection Committee. 2023 - present. MemberIntegrative Medicine Award Research Review Committee / CLL Society. 2018 ...

  6. Hairy Cell Leukemia Clinical Trials - Mayo Clinic Research

    ... chronic lymphocytic leukemia (CLL). The Circulating Cell-free Genome Atlas Study Scottsdale/Phoenix, AZ; Jacksonville, FL; Rochester, MN. GRAIL is using deep ...

  7. Study to Assess the Safety and Effectiveness of Shingrix Vaccine in Patients with Hematologic Malignancies - Mayo Clinic

    ... CLL to patients with untreated intermediate and high-risk CLL. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

  8. Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003) - Mayo Clinic

    ... chronic lymphocytic leukemia (CLL)/ small lymphocytic lymphoma (SLL), Richter's transformation, marginal zone lymphoma (MZL), mantle cell lymphoma (MCL) ...

  9. Cancer Clinical Trials - Medical Professionals

    A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL).

  10. Clinical trials - Oncology (Medical)

    Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...